NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)
$42.53 -0.92 (-2.1174%)
Analysed NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) News Sources
Novo Nordisk Is Dropping Some Weight. Can a Rebrand Save the Stock?
14-09-2026
yahoo.com
Novo Nordisk Rebrands as ‘Novo': Stock Falls as Company Aims GLP-1s at Consumers
15-09-2026
beincrypto.com
No Mo’ Nordisk: Ozempic Maker Rebrands as Novo, Promises New Culture
15-09-2026
thedailyupside.com
Novo Nordisk (NVO) Unveils Global Rebrand As Novo
15-09-2026
yahoo.com
Novo Nordisk (CPSE:NOVO B) Rebrands As Novo In Consumer Health Push
15-09-2026
yahoo.com
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
15-09-2026
fool.com
From Novo Nordisk to ‘Novo’: A Strategic Reset Amid Rising Lilly Pressure
15-09-2026
yahoo.com
Novo Nordisk Stock Falls After Major Rebrand
15-09-2026
yahoo.com
Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption
15-09-2026
247wallst.com
3 Absurdly Cheap Growth Stocks to Buy Before the End of 2026
15-09-2026
fool.com
What is the current price of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)?
The current price of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) is $42.53.
NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) absolute price change since previous trading day?
The absolute price change of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) since the previous trading day is $-0.92.
NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) percentage price change since previous trading day?
The percentage price change of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) since the previous trading day is -2.1174%.
What is the most recent average sentiment score for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)?
The most recent average sentiment score for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) is 55 out of 100.
What is the most recent average sentiment for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)?
The most recent sentiment for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) is .
SEC-8K** Filing Available For NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.